Literature DB >> 25435727

Ocular manifestations in egyptian children and young adults with sickle cell disease.

Mona Kamal El-Ghamrawy1, Hanan F El Behairy2, Amal El Menshawy2, Seham A Awad2, Ahmed Ismail3, Mohamed Salah Gabal4.   

Abstract

In sickle cell disease (SCD), ocular lesions result from stasis and occlusion of small eye vessels by sickled erythrocytes. Vaso-occlusive disease of the retina can be responsible for nonproliferative (NPR) and proliferative retinopathy (PR). Patients are often asymptomatic until serious complications arise as, vitreous hemorrhage and retinal detachment. This work aimed to study the frequency and pattern of ocular manifestations in Egyptian children and young adults with SCD. In this cross-sectional study, 40 steady state patients (80 eyes) aged 2-28 years (30 children and 10 young adults) with established diagnosis of SCD (26 with homozygous SS and 14 with S/β thalassemia underwent complete ophthalmic examination with dilated fundoscopy. Fluorescein angiography was performed for patients ≥12 years old. The overall frequency of retinal lesions was 47.5 % (46.2 and 50 % of SS and S/β patients respectively). PR and NPR were evident in 32.5 and 27.5 % of all enrolled patients respectively (five patients having both). Peripheral retinal occlusion was a frequent ocular finding in both groups; the youngest patient showing PR was 15 years old. Older age, longer disease duration and splenectomy were significantly more prevalent among patients with PR. Despite lack of visual symptoms, children and young adults are at risk of PR. Frequency of retinal lesions was comparable in SS and S/β patients. Periodic ophthalmologic examination starting at the age of 12 years is recommended for timely-identification of retinal lesions thus minimizing the risk of sight threatening retinopathy.

Entities:  

Keywords:  Children; Ocular; Retinopathy; Sickle cell disease

Year:  2014        PMID: 25435727      PMCID: PMC4243417          DOI: 10.1007/s12288-014-0333-0

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  24 in total

1.  [Ocular and electroretinographic changes in sickle cell disease].

Authors:  Renato Cunha David; Haroldo Vieira de Moraes Júnior; Márcio Penha Morterá Rodrigues
Journal:  Arq Bras Oftalmol       Date:  2011 May-Jun       Impact factor: 0.872

2.  Sickle cell retinopathy in Jamaican children: further observations from a cohort study.

Authors:  J F Talbot; A C Bird; G H Maude; R W Acheson; B J Moriarty; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1988-10       Impact factor: 4.638

3.  Classification and pathogenesis of proliferative sickle retinopathy.

Authors:  M F Goldberg
Journal:  Am J Ophthalmol       Date:  1971-03       Impact factor: 5.258

4.  Clinical and laboratory factors associated with the severity of proliferative sickle cell retinopathy in patients with sickle cell hemoglobin C (SC) and homozygous sickle cell (SS) disease.

Authors:  Nicolas Leveziel; Sylvie Bastuji-Garin; Franck Lalloum; Giuseppe Querques; Pascale Benlian; Michel Binaghi; Gabriel Coscas; Gisèle Soubrane; Dora Bachir; Frédéric Galactéros; Eric H Souied
Journal:  Medicine (Baltimore)       Date:  2011-11       Impact factor: 1.889

5.  Ocular findings in sickle cell disease patients in Lagos.

Authors:  F B Akinsola; M O Kehinde
Journal:  Niger Postgrad Med J       Date:  2004-09

Review 6.  Ocular manifestations of sickle cell disease.

Authors:  A O Fadugbagbe; R Q Gurgel; C Q Mendonça; R Cipolotti; A M dos Santos; L E Cuevas
Journal:  Ann Trop Paediatr       Date:  2010

7.  When should children and young adults with sickle cell disease be referred for eye assessment?

Authors:  O E Babalola; C O Wambebe
Journal:  Afr J Med Med Sci       Date:  2001-12

8.  Prevention of hemoglobinopathies in Egypt.

Authors:  Amal El-Beshlawy; Ilham Youssry
Journal:  Hemoglobin       Date:  2009       Impact factor: 0.849

9.  [Retinal impairment in young individuals with sickle cell anemia (hemoglobin SS disease) in university hospital in Northeastern of Brazil].

Authors:  Allisson Mário dos Santos; Gustavo Baptista de Almeida Faro; Marcus Vinicius Melo do Amaral; Cristiano de Queiroz Mendonça; Bruno Campelo Leal; Rosana Cipolotti
Journal:  Arq Bras Oftalmol       Date:  2012-10       Impact factor: 0.872

Review 10.  Sickle cell retinopathy: diagnosis and treatment.

Authors:  Maria Teresa Brizzi Chizzotti Bonanomi; Marcelo Mendes Lavezzo
Journal:  Arq Bras Oftalmol       Date:  2013-10       Impact factor: 0.872

View more
  6 in total

Review 1.  New Ways to Detect Pediatric Sickle Cell Retinopathy: A Comprehensive Review.

Authors:  Daniel A Pahl; Nancy S Green; Monica Bhatia; Royce W S Chen
Journal:  J Pediatr Hematol Oncol       Date:  2017-11       Impact factor: 1.289

Review 2.  Sickle cell retinopathy: improving care with a multidisciplinary approach.

Authors:  Farid Menaa; Barkat Ali Khan; Bushra Uzair; Abder Menaa
Journal:  J Multidiscip Healthc       Date:  2017-08-30

3.  Ocular manifestations of sickle cell disease.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  Taiwan J Ophthalmol       Date:  2018 Jan-Mar

4.  Reply to comment on: "Ocular manifestations of sickle cell disease and genetic susceptibility for refractive errors".

Authors:  Palak Shukla; Henu Verma; Santosh Patel; P K Patra; L V K S Bhaskar
Journal:  Taiwan J Ophthalmol       Date:  2018 Jan-Mar

5.  Co-occurrence of sickle cell disease and oculocutaneous albinism in a Congolese patient: a case report.

Authors:  Benoît Mbiya Mukinayi; John Mpoyi Kalenda; Didier Kalombo Kalenda; Ghislain Disashi Tumba; Béatrice Gulbis
Journal:  J Med Case Rep       Date:  2021-12-19

6.  Retinopathy in Egyptian patients with sickle cell disease: A cross-sectional study.

Authors:  Tamer Hassan; Mohamed Badr; Diana Hanna; Mohamed Arafa; Ahmed Elhewala; Sherief Dabour; Saad Shehata; Doaa Abdel Rahman
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.